{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T16:45:08Z","timestamp":1790181908053,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular and Cellular Endocrinology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.mce.2025.112614","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T11:29:02Z","timestamp":1752578942000},"page":"112614","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Association between BRAFV600E mutation and gene expression of CLDN1, TIMP1, and KRT19 in papillary thyroid cancer"],"prefix":"10.1016","volume":"607","author":[{"given":"Andrea","family":"Ross-Orozco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6043-7760","authenticated-orcid":false,"given":"Anette Roxana","family":"Gastelum-Quiroz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1795-5415","authenticated-orcid":false,"given":"Marco","family":"Alvarez-Arrazola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred","family":"Luque-Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3390-7683","authenticated-orcid":false,"given":"Alejandra","family":"Mart\u00ednez-Camberos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karla","family":"Morales-Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9775-3062","authenticated-orcid":false,"given":"F.","family":"Lopez-Herrera y Cairo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8442-2873","authenticated-orcid":false,"given":"Noem\u00ed","family":"Garc\u00eda-Magallanes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mce.2025.112614_bib1","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3390\/cancers14010204","article-title":"Emerging biomarkers in thyroid practice and research","volume":"14","author":"Agarwal","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.mce.2025.112614_bib2","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-39747-6","article-title":"Predicting BRAFV600E mutations in papillary thyroid carcinoma using six machine learning algorithms based on ultrasound elastography","volume":"13","author":"Agyekum","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mce.2025.112614_bib3","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S2213-8587(22)00101-2","article-title":"Diagnosis of thyroid nodules","volume":"10","author":"Alexander","year":"2022","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.mce.2025.112614_bib4","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1530\/ERC-11-0076","article-title":"BRAFV600E mutation, TIMP-1 upregulation, and NF-\u03baB activation: closing the loop on the papillary thyroid cancer trilogy","volume":"18","author":"Bommarito","year":"2011","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.mce.2025.112614_bib5","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.tranon.2014.05.009","article-title":"Claudin-1 expression is elevated in colorectal cancer precursor lesions harboring the BRAF V600E mutation","volume":"7","author":"Caruso","year":"2014","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.mce.2025.112614_bib6","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/cam4.4419","article-title":"BRAFV600E mutation test on fine\u2010needle aspiration specimens of thyroid nodules: clinical correlations for 4600 patients","volume":"11","author":"Chen","year":"2021","journal-title":"Cancer Med."},{"key":"10.1016\/j.mce.2025.112614_bib7","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.3390\/ijms24044057","article-title":"Expanding the spectrum of BRAF Non-V600E mutations in thyroid nodules: evidence-based data from a tertiary referral centre","volume":"24","author":"De Leo","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mce.2025.112614_bib8","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2147\/TACG.S412364","article-title":"Profile of BRAFV600E, BRAFK601E, NRAS, HRAS, and KRAS mutational status, and clinicopathological characteristics of papillary thyroid carcinoma in Indonesian national referral hospital","volume":"16","author":"Harahap","year":"2023","journal-title":"Appl. Clin. Genet."},{"key":"10.1016\/j.mce.2025.112614_bib9","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s12874-024-02198-2","article-title":"Methods of determining optimal cut-point of diagnostic biomarkers with application of clinical data in ROC analysis: an update review","volume":"24","author":"Hassanzad","year":"2024","journal-title":"BMC Med. Res. Methodol."},{"key":"10.1016\/j.mce.2025.112614_bib10","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/cdd.2014.155","article-title":"Cytokeratin19 induced by HER2\/ERK binds and stabilizes HER2 on cell membranes","volume":"22","author":"Ju","year":"2015","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.mce.2025.112614_bib11","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/SLA.0b013e318148563d","article-title":"The prevalence and prognostic value of BRAF mutation in thyroid cancer","volume":"246","author":"Kebebew","year":"2007","journal-title":"Ann. Surg."},{"key":"10.1016\/j.mce.2025.112614_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.ygeno.2024.110914","article-title":"TIMP1 promotes thyroid cancer cell progression through macrophage phenotypic polarization via the PI3K\/AKT signaling pathway","volume":"116","author":"Lin","year":"2024","journal-title":"Genomics"},{"key":"10.1016\/j.mce.2025.112614_bib13","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.21037\/gs.2017.08.04","article-title":"Current methodologies for molecular screening of thyroid nodules","volume":"7","author":"Macerola","year":"2018","journal-title":"Gland Surg."},{"key":"10.1016\/j.mce.2025.112614_bib14","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.bbrc.2022.05.093","article-title":"Dysregulation of KRT19, TIMP1, and CLDN1 gene expression is associated with thyroid cancer","volume":"617","author":"Mart\u00ednez-Camberos","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.mce.2025.112614_bib15","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.circir.2016.05.017","article-title":"Mecanismos de se\u00f1alizaci\u00f3n intracelular en c\u00e1ncer de tiroides","volume":"84","author":"Mondrag\u00f3n-Ter\u00e1n","year":"2016","journal-title":"Cirug\u00eda Cir."},{"key":"10.1016\/j.mce.2025.112614_bib16","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/MED.0000000000000829","article-title":"Molecular testing for indeterminate thyroid nodules: past, present, and future","volume":"30","author":"Raghunathan","year":"2023","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"10.1016\/j.mce.2025.112614_bib17","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.3390\/cancers16061215","article-title":"Mutations in the serine\/threonine kinase BRAF: oncogenic drivers in solid tumors","volume":"16","author":"Roa","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.mce.2025.112614_bib18","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/CCO.0000000000000797","article-title":"BRAF mutations in thyroid cancer","volume":"34","author":"Scheffel","year":"2022","journal-title":"Curr. Opin. Oncol."},{"key":"10.1016\/j.mce.2025.112614_bib19","doi-asserted-by":"crossref","first-page":"E338","DOI":"10.1210\/jc.2013-2792","article-title":"RNA sequencing identifies multiple fusion transcripts, differentially expressed genes, and reduced expression of immune function genes in BRAF (V600E) mutant vs BRAF wild-type papillary thyroid carcinoma","volume":"99","author":"Smallridge","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2025.112614_bib20","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.3390\/genes11111342","article-title":"Emerging BRAF mutations in cancer progression and their possible effects on transcriptional networks","volume":"11","author":"\u015amiech","year":"2020","journal-title":"Genes"},{"key":"10.1016\/j.mce.2025.112614_bib21","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s13046-016-0427-7","article-title":"TIMP1 is a prognostic marker for the progression and metastasis of colon cancer through FAK-PI3K\/AKT and MAPK pathway","volume":"35","author":"Song","year":"2016","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.mce.2025.112614_bib22","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.tibtech.2018.12.002","article-title":"The ultimate qPCR experiment: producing publication quality, reproducible data the first time","volume":"37","author":"Taylor","year":"2019","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.mce.2025.112614_bib23","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ecl.2018.10.003","article-title":"Coding molecular determinants of thyroid cancer development and progression","volume":"48","author":"Valvo","year":"2019","journal-title":"Endocrinol Metab. Clin. N. Am."}],"container-title":["Molecular and Cellular Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720725001650?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720725001650?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T11:57:13Z","timestamp":1777550233000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303720725001650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":23,"alternative-id":["S0303720725001650"],"URL":"https:\/\/doi.org\/10.1016\/j.mce.2025.112614","relation":{},"ISSN":["0303-7207"],"issn-type":[{"value":"0303-7207","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between BRAFV600E mutation and gene expression of CLDN1, TIMP1, and KRT19 in papillary thyroid cancer","name":"articletitle","label":"Article Title"},{"value":"Molecular and Cellular Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mce.2025.112614","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112614"}}